Cargando…

Dangers of hyperoxia

Oxygen (O(2)) toxicity remains a concern, particularly to the lung. This is mainly related to excessive production of reactive oxygen species (ROS). Supplemental O(2), i.e. inspiratory O(2) concentrations (F(I)O(2)) > 0.21 may cause hyperoxaemia (i.e. arterial (a) PO(2) > 100 mmHg) and, subseq...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Mervyn, Young, Paul J., Laffey, John G., Asfar, Pierre, Taccone, Fabio Silvio, Skrifvars, Markus B., Meyhoff, Christian S., Radermacher, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686263/
https://www.ncbi.nlm.nih.gov/pubmed/34924022
http://dx.doi.org/10.1186/s13054-021-03815-y
_version_ 1784617981268983808
author Singer, Mervyn
Young, Paul J.
Laffey, John G.
Asfar, Pierre
Taccone, Fabio Silvio
Skrifvars, Markus B.
Meyhoff, Christian S.
Radermacher, Peter
author_facet Singer, Mervyn
Young, Paul J.
Laffey, John G.
Asfar, Pierre
Taccone, Fabio Silvio
Skrifvars, Markus B.
Meyhoff, Christian S.
Radermacher, Peter
author_sort Singer, Mervyn
collection PubMed
description Oxygen (O(2)) toxicity remains a concern, particularly to the lung. This is mainly related to excessive production of reactive oxygen species (ROS). Supplemental O(2), i.e. inspiratory O(2) concentrations (F(I)O(2)) > 0.21 may cause hyperoxaemia (i.e. arterial (a) PO(2) > 100 mmHg) and, subsequently, hyperoxia (increased tissue O(2) concentration), thereby enhancing ROS formation. Here, we review the pathophysiology of O(2) toxicity and the potential harms of supplemental O(2) in various ICU conditions. The current evidence base suggests that PaO(2) > 300 mmHg (40 kPa) should be avoided, but it remains uncertain whether there is an “optimal level” which may vary for given clinical conditions. Since even moderately supra-physiological PaO(2) may be associated with deleterious side effects, it seems advisable at present to titrate O(2) to maintain PaO(2) within the normal range, avoiding both hypoxaemia and excess hyperoxaemia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03815-y.
format Online
Article
Text
id pubmed-8686263
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86862632021-12-20 Dangers of hyperoxia Singer, Mervyn Young, Paul J. Laffey, John G. Asfar, Pierre Taccone, Fabio Silvio Skrifvars, Markus B. Meyhoff, Christian S. Radermacher, Peter Crit Care Review Oxygen (O(2)) toxicity remains a concern, particularly to the lung. This is mainly related to excessive production of reactive oxygen species (ROS). Supplemental O(2), i.e. inspiratory O(2) concentrations (F(I)O(2)) > 0.21 may cause hyperoxaemia (i.e. arterial (a) PO(2) > 100 mmHg) and, subsequently, hyperoxia (increased tissue O(2) concentration), thereby enhancing ROS formation. Here, we review the pathophysiology of O(2) toxicity and the potential harms of supplemental O(2) in various ICU conditions. The current evidence base suggests that PaO(2) > 300 mmHg (40 kPa) should be avoided, but it remains uncertain whether there is an “optimal level” which may vary for given clinical conditions. Since even moderately supra-physiological PaO(2) may be associated with deleterious side effects, it seems advisable at present to titrate O(2) to maintain PaO(2) within the normal range, avoiding both hypoxaemia and excess hyperoxaemia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03815-y. BioMed Central 2021-12-19 /pmc/articles/PMC8686263/ /pubmed/34924022 http://dx.doi.org/10.1186/s13054-021-03815-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Singer, Mervyn
Young, Paul J.
Laffey, John G.
Asfar, Pierre
Taccone, Fabio Silvio
Skrifvars, Markus B.
Meyhoff, Christian S.
Radermacher, Peter
Dangers of hyperoxia
title Dangers of hyperoxia
title_full Dangers of hyperoxia
title_fullStr Dangers of hyperoxia
title_full_unstemmed Dangers of hyperoxia
title_short Dangers of hyperoxia
title_sort dangers of hyperoxia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686263/
https://www.ncbi.nlm.nih.gov/pubmed/34924022
http://dx.doi.org/10.1186/s13054-021-03815-y
work_keys_str_mv AT singermervyn dangersofhyperoxia
AT youngpaulj dangersofhyperoxia
AT laffeyjohng dangersofhyperoxia
AT asfarpierre dangersofhyperoxia
AT tacconefabiosilvio dangersofhyperoxia
AT skrifvarsmarkusb dangersofhyperoxia
AT meyhoffchristians dangersofhyperoxia
AT radermacherpeter dangersofhyperoxia